Qube Research & Technologies (QRT)’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.41M | Buy |
349,661
+55,962
| +19% | +$865K | 0.01% | 1211 |
|
2025
Q1 | $4.37M | Buy |
293,699
+113,761
| +63% | +$1.69M | 0.01% | 1262 |
|
2024
Q4 | $2.38M | Buy |
179,938
+49,821
| +38% | +$660K | ﹤0.01% | 1431 |
|
2024
Q3 | $1.85M | Buy |
+130,117
| New | +$1.85M | ﹤0.01% | 1440 |
|
2024
Q2 | – | Sell |
-114,209
| Closed | -$1.59M | – | 4153 |
|
2024
Q1 | $1.59M | Sell |
114,209
-319,309
| -74% | -$4.44M | ﹤0.01% | 1600 |
|
2023
Q4 | $6.19M | Buy |
433,518
+146,813
| +51% | +$2.1M | 0.01% | 777 |
|
2023
Q3 | $4.44M | Sell |
286,705
-444,953
| -61% | -$6.88M | 0.01% | 784 |
|
2023
Q2 | $11.5M | Buy |
731,658
+394,761
| +117% | +$6.2M | 0.04% | 463 |
|
2023
Q1 | $5.55M | Buy |
+336,897
| New | +$5.55M | 0.02% | 580 |
|
2022
Q2 | – | Sell |
-218,322
| Closed | -$3.13M | – | 3091 |
|
2022
Q1 | $3.13M | Buy |
218,322
+15,874
| +8% | +$227K | 0.03% | 638 |
|
2021
Q4 | $2.76M | Buy |
202,448
+7,368
| +4% | +$100K | 0.02% | 717 |
|
2021
Q3 | $3.2M | Buy |
+195,080
| New | +$3.2M | 0.04% | 546 |
|
2021
Q2 | – | Sell |
-188,713
| Closed | -$3.45M | – | 2779 |
|
2021
Q1 | $3.45M | Sell |
188,713
-9,598
| -5% | -$175K | 0.05% | 451 |
|
2020
Q4 | $3.61M | Sell |
198,311
-280,588
| -59% | -$5.11M | 0.05% | 400 |
|
2020
Q3 | $8.54M | Buy |
478,899
+352,389
| +279% | +$6.29M | 0.12% | 209 |
|
2020
Q2 | $2.27M | Buy |
+126,510
| New | +$2.27M | 0.03% | 620 |
|
2020
Q1 | – | Sell |
-94,412
| Closed | -$1.86M | – | 1642 |
|
2019
Q4 | $1.86M | Buy |
94,412
+64,525
| +216% | +$1.27M | 0.06% | 384 |
|
2019
Q3 | $514K | Sell |
29,887
-2,913
| -9% | -$50.1K | 0.34% | 85 |
|
2019
Q2 | $581K | Buy |
+32,800
| New | +$581K | 0.14% | 160 |
|
2019
Q1 | – | Sell |
-69,304
| Closed | -$1.17M | – | 470 |
|
2018
Q4 | $1.17M | Buy |
+69,304
| New | +$1.17M | 0.5% | 27 |
|